Patients with autoimmune conditions or endocrine sensitivity should also be evaluated carefully before initiating therapy
While most microorganisms are harmless or even beneficial, caution is needed when it comes to the spread of (opportunistic) pathogens
Originally developed to improve glycemic control in type 2 diabetes, drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have proven remarkably effective at helping patients lose weight
its also reported that tirzepatide resulted in greater weight loss than dulaglutide, which is good news for patients because of its recent FDA approval for weight loss
In a case report by Sani et al., the use of semaglutide 1 mg weekly over 12 months in a male with PWS and diabetes resulted in an HbA1c decrease of 3.9% and weight loss of 5.2 kg (41)
- Common in Type 1 Diabetes, but can occur in Type 2 under stress (infection, MI, etc.)